Androgen receptor-mediated CD8+ T cell stemness programs drive sex differences in antitumor immunity

Immunity. 2022 Sep 13;55(9):1747. doi: 10.1016/j.immuni.2022.07.016.
No abstract available

Publication types

  • Published Erratum